One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study

One-Year Outcomes of Aflibercept in Treat-and-Extend Versus Pro Re Nata Regimens for Bevacizumab-Resistant Diabetic Macular Edema: A Real-World Study

Abstract Introduction The aim of this study was to compare the efficacy of the treat-and-extend (TAE) regimen versus the pro re nata (PRN) regimen in patients with bevacizumab-resistant diabetic macular edema (DME) treated with aflibercept, with or without adjunctive laser therapy. Methods Ninety-on...

Full description

Saved in:
Bibliographic Details
Main Authors: Zubeyir Yozgat, Mehmed Ugur Isik, Mehmet Cem Sabaner
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-11-01
Series:Ophthalmology and Therapy
Subjects:
Aflibercept
Bevacizumab-resistant
Diabetic macular edema
Pro re nata regimen
Real-world study
Treat-and-extend regimen
Online Access:https://doi.org/10.1007/s40123-024-01067-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40123-024-01067-x

Similar Items